Latest Articles
- Fragility fractures in chronic kidney disease: An opinion-based approach
When a patient with chronic kidney disease suffers a fragility fracture, a key question is whether the patient has osteoporosis or, instead, renal osteodystrophy. Bone densitometry does not help in this distinction.
- Prasugrel for acute coronary syndromes: Faster, more potent, but higher bleeding risk
Prasugrel (Effient) is faster and more consistent in its effects, but patients at high bleeding risk should still receive clopidogrel (Plavix).
- An algorithm for managing warfarin resistance
Some patients need higher-than-expected doses of warfarin to reach their target INR. The cause can be acquired (poor compliance, drug interactions) or hereditary.
- Low bone density is not always bisphosphonate deficiency
Low bone density is not a one-size-fits-all disorder. We need to carefully consider the diagnostic and therapeutic options before assuming that low bone density is osteoporosis.
- Current therapies to shorten postoperative ileus
Rather than merely wait for bowel sounds to return after patients undergo surgery, we can try to get the gut working again sooner.
- Dual antiplatelet therapy in coronary artery disease: A case-based approach
Many patients need the combination of aspirin and clopidogrel (Plavix) or prasugrel (Effient) to reduce their risk of cardiovascular events, as shown in recent trials.